Bruce Cheson Selected Research

PRO131921 monoclonal antibody

9/2014

A phase I study of PRO131921, a novel anti-CD20 monoclonal antibody in patients with relapsed/refractory CD20+ indolent NHL: correlation between clinical responses and AUC pharmacokinetics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bruce Cheson Research Topics

Disease

4	Neoplasms (Cancer) 04/2016 - 03/2007
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2016 - 01/2002
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2021 - 09/2014
2	Hodgkin Disease (Hodgkin's Disease) 10/2018 - 06/2008
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 04/2016 - 02/2006
2	Lymphoma (Lymphomas) 09/2014 - 03/2007
2	Leukemia 03/2007 - 02/2006
1	Pneumonia (Pneumonitis) 04/2016
1	Diarrhea 04/2016
1	Multiple Myeloma 01/2011
1	Residual Neoplasm 02/2006
1	Disease Progression 02/2006

Drug/Important Bio-Agent (IBA)

4	Rituximab (Mabthera)FDA Link 04/2016 - 01/2011
3	Pharmaceutical PreparationsIBA 04/2016 - 03/2007
2	Proteins (Proteins, Gene)FDA Link 06/2008 - 02/2006
1	Transaminases (Aminotransferases)IBA 04/2016
1	idelalisibIBA 04/2016
1	LigandsIBA 09/2014
1	PRO131921 monoclonal antibodyIBA 09/2014
1	AntimetabolitesIBA 01/2011
1	Bendamustine Hydrochloride FDA Link 01/2011
1	Cytotoxins (Cytolysins)IBA 01/2011
1	Nucleoside Transport Proteins (Nucleoside Transporter)IBA 06/2008
1	liposomal doxorubicin (Doxil)FDA Link 06/2008
1	Vinorelbine (Navelbine)FDA LinkGeneric 06/2008
1	Gemcitabine FDA Link 06/2008
1	Biomarkers (Surrogate Marker)IBA 03/2007
1	Monoclonal AntibodiesIBA 01/2002
1	tositumomab I-131 (Bexxar)FDA Link 01/2002

Therapy/Procedure

5	Therapeutics 01/2021 - 02/2006
1	Drug Therapy (Chemotherapy) 03/2007